Companies / Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc.
GBTCIK 1629137
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | Farrow Jeffrey S Executive | Sell Open-market sale | Common Stock | $2.14M | -31K -91.06% | 3,086 | medium |
| Feb 1, 2021 | Love Ted W CEO | Other Withheld for taxes | Common Stock | $885.5K | -18K -2.26% | 773,941 | low |
| Sep 1, 2022 | Love Ted W CEO | Other Withheld for taxes | Common Stock | $627.0K | -9K -1.12% | 814,527 | low |
| Aug 1, 2021 | Love Ted W CEO | Other Withheld for taxes | Common Stock | $405.9K | -15K -1.85% | 789,413 | low |
| Aug 1, 2021 | Love Ted W CEO | Other Withheld for taxes | Common Stock | $405.9K | -15K -1.85% | 789,413 | low |
| Sep 27, 2022 | Farrow Jeffrey S Executive | Exercise Option exercise | Common Stock | $387.9K | +24K +766.46% | 26,739 | low |
| Aug 1, 2022 | Love Ted W CEO | Other Withheld for taxes | Common Stock | $324.6K | -10K -1.23% | 805,174 | low |
| Aug 18, 2022 | Habibizad Nazila Executive | Sell Open-market sale | Common Stock | $314.3K | -5K -34.41% | 8,918 | medium |